RILASTIL XEROLACT PB BALM 400ML
Rilastil Xerolact PB (Pre-and Post-Biotic) is an intensive lipid-replenishing and anti-irritation balm designed to provide 48-hour hydration. Specifically formulated for very dry skin prone to atopic dermatitis, this balm focuses on rebalancing the skin’s microbiome to prevent flare-ups and provide lasting comfort.
27.95 د.ا
Only 3 left in stock
Add to wishlist Add to compareAsk about productDescription
Product Information
-
Product Name: Rilastil Xerolact PB Balm
-
Category: Anti-Irritation Lipid-Replenishing Balm
-
Problem it solves: This balm addresses the cycle of severe dryness, intense itching, and redness associated with atopic-prone skin. It targets the “itch-scratch” cycle by soothing the skin and restoring its microbial diversity.
-
Key benefits:
-
Helps to soothe skin immediately, reducing itching and redness within seconds of application.
-
Supports the restoration of the skin’s natural microbiome to prolong the periods between flare-ups.
-
Contributes to 48 hours of continuous hydration and nourishment.
-
Promotes a stronger skin barrier, making it more resilient against environmental triggers.
-
-
Ingredients or features:
-
Prebiotics (Alpha-Glucan Oligosaccharide): Feeds the “good” bacteria on the skin to maintain a healthy balance.
-
Postbiotics (Lactobacillus Ferment): Helps to calm inflammation and strengthen the skin’s defense system.
-
Skin Barrier Self-Repair Complex: A blend of Ceramides and Fatty Acids that mimics the skin’s natural structure.
-
Schisandra chinensis: An active ingredient that restores skin elasticity and comfort.
-
-
How to use: Apply once or twice daily to the face and body, preferably after bathing or showering while the skin is still slightly damp. Massage gently until completely absorbed.
-
Target audience: Infants, children, and adults with very dry, irritated, or atopic-prone skin. It is suitable for the most sensitive skin types.
-
Requirements: For external use only. Fragrance-free and hypoallergenic.








Reviews
There are no reviews yet.